Ozempic – Breaking News & Latest Updates 2026
Skip to main content
M
External Link
It finally happened.

According to the FDA, there is no longer a shortage of semaglutide, the active ingredient in the wildly popular Ozempic and Wegovy — a very bad omen for the countless telehealth and pharmacy businesses selling “compounded” versions of the diabetes and weight-loss drug. The FDA has clarified that state-licensed and out-sourcing operations have to cease production of the “compounded” medication by April 22nd and May 22nd, respectively.

Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.
Comments
Loading comments
Getting the conversation ready...